Skip to main content
. Author manuscript; available in PMC: 2010 May 15.
Published in final edited form as: Biochem Biophys Res Commun. 2009 Mar 19;382(4):657–662. doi: 10.1016/j.bbrc.2009.03.080

Table 1.

Peptides used in study.

Compound Sequence
TAT (d)1-Ac-RKKRR-Orn-RRR-COOH
NLS Ac-KKKRKV-COOH
TAT-BH4 (d)1-Ac-RKKRR-Orn-RRR-β-A-(l)1-SNRELVVDFLSYKLSQKGYS-COOH
TAT-BH4i (d)1-Ac-RKKRR-Orn-RRR-β-A-(l)1-SNRELVVDFLSDKLSQKGDS-COOH
NLS-BH4 Ac-KKKRKV-β-A-(l)1-SNRELVVDFLSYKLSQKGYS-COOH
NLS-BH4i Ac-KKKRKV-β-A-(l)1-SNRELVVDFLSDKLSQKGDS-COOH
FITC-TAT-BH4 (d)1-Ac-C(FM) RKKRR-Orn-RRR-β-A-(l)1-SNRELVVDFLSYKLSQKGYS-COOH
FITC-NLS-BH4 (d)1-Ac-C(FM) KKKRKV-β-A-(l)1-SNRELVVDFLSYKLSQKGYS-COOH
1

(d) indicates that the subsequent amino acids are D-amino acids while (l) indicates that the subsequent amino acids are L-amino acids. Unmarked sequences are composed entirely of L-amino acids.